SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-25-001969 to Arrive AI Inc. (ARAI)

Arrive AI Inc.
Date: Feb. 20, 2025 · CIK: 0001818274 · Accession: 0000000000-25-001969

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-284042

Date
February 20, 2025
Author
Daniel S. O'Toole
Form
UPLOAD
Company
Arrive AI Inc.

Letter

February 20, 2025 Daniel S. O'Toole Chief Executive Officer Arrive AI Inc. 12175 Visionary Way Fishers, Indiana 46038 Re:Arrive AI Inc. Amendment No. 1 to Registration Statement on Form S-1 Filed January 27, 2025 File No. 333-284042 Dear Daniel S. O'Toole: We have reviewed your amended registration statement and have the following comment(s). Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe a comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to this letter, we may have additional comments. Unless we note otherwise, any references to prior comments are to comments in our January 22, 2025 letter. Amendment No. 1 to Registration Statement on Form S-1 Filed January 27, 2025 Risk Factors If we materially breach the Exclusive Patent License Agreement..., page 13 1.We note that you added this risk factor in response to prior comment 7. Please revise to remove the mitigating language "[a]lthough unlikely to happen" as it mitigates the risk presented here. Additionally, please appropriately state the risk to investors if Mr. O'Toole terminates the Exclusive Patent License Agreement. Business, page 31 We note your amended disclosure in response to prior comment 3 and we reissue in part. With respect to your customer agreements/SOWs and your agreements for installing AP3 units that you plan to provide to MaaS in 2025, please revise to 2.

February 20, 2025 Page 2 disclose the material terms of such agreements. To the extent that you believe certain portions of the agreements are confidential, please consider using Rule 83 to request confidential treatment of information or Item 601(b)(10)(iv) to make certain redactions. 3.We note your amended disclosure in response to prior comment 2. To the extent material, please revise to describe the various types of software that you anticipate using in your business. Make it clear, if true, that you do not currently and may never use such software because its use is aspirational in nature. Executive and Director Compensation, page 52 4.Please revise to include the disclosure required for the most recently completed fiscal year. Refer to Item 402 of Regulation S-K. Principal and Registered Stockholders, page 57 5.We note your amended disclosure in response to prior comment 8. Please individually identify and provide the holdings of the "affiliates to the Company or considered insiders" that hold in the aggregate 552,484 of the shares included in the "All Other Stockholders" group. Plan of Distribution, page 61 6.We note your amended disclosure in response to prior comment 1, however you did not update your Plan of Distribution disclosure as requested. In this section, please revise to state that the shares you are registering represent 100% of the company's currently issued and outstanding common stock and that all such shares may be freely sold upon effectiveness of the registration statement. State that none of your outstanding shares may be freely sold in reliance on an exemption from registration such as Rule 144 at this time. Exhibit Index Exhibit 23.1, page II-5 7.Please have the consent revised to refer to the correct registration form being filed. Please contact Aamira Chaudhry at 202-551-3389 or Doug Jones at 202-551-3309 if you have questions regarding comments on the financial statements and related matters. Please contact Cara Wirth at 202-551-7127 or Lilyanna Peyser at 202-551-3222 with any other questions. Sincerely, Division of Corporation Finance Office of Trade & Services cc:Joseph Lucosky

Show Raw Text
February 20, 2025
Daniel S. O'Toole
Chief Executive Officer
Arrive AI Inc.
12175 Visionary Way
Fishers, Indiana 46038
Re:Arrive AI Inc.
Amendment No. 1 to Registration Statement on Form S-1
Filed January 27, 2025
File No. 333-284042
Dear Daniel S. O'Toole:
            We have reviewed your amended registration statement and have the following
comment(s).
            Please respond to this letter by amending your registration statement and providing
the requested information. If you do not believe a comment applies to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
            After reviewing any amendment to your registration statement and the information
you provide in response to this letter, we may have additional comments. Unless we note
otherwise, any references to prior comments are to comments in our January 22, 2025 letter.
Amendment No. 1 to Registration Statement on Form S-1 Filed January 27, 2025
Risk Factors
If we materially breach the Exclusive Patent License Agreement..., page 13
1.We note that you added this risk factor in response to prior comment 7. Please revise
to remove the mitigating language "[a]lthough unlikely to happen" as it mitigates the
risk presented here. Additionally, please appropriately state the risk to investors if Mr.
O'Toole terminates the Exclusive Patent License Agreement.
Business, page 31
We note your amended disclosure in response to prior comment 3 and we reissue in
part. With respect to your customer agreements/SOWs and your agreements for
installing AP3 units that you plan to provide to MaaS in 2025, please revise to 2.

February 20, 2025
Page 2
disclose the material terms of such agreements. To the extent that you believe certain
portions of the agreements are confidential, please consider using Rule 83 to request
confidential treatment of information or Item 601(b)(10)(iv) to make certain
redactions.
3.We note your amended disclosure in response to prior comment 2. To the extent
material, please revise to describe the various types of software that you anticipate
using in your business. Make it clear, if true, that you do not currently and may never
use such software because its use is aspirational in nature.
Executive and Director Compensation, page 52
4.Please revise to include the disclosure required for the most recently completed fiscal
year. Refer to Item 402 of Regulation S-K.
Principal and Registered Stockholders, page 57
5.We note your amended disclosure in response to prior comment 8. Please individually
identify and provide the holdings of the "affiliates to the Company or considered
insiders" that hold in the aggregate 552,484 of the shares included in the "All Other
Stockholders" group.
Plan of Distribution, page 61
6.We note your amended disclosure in response to prior comment 1, however you did
not update your Plan of Distribution disclosure as requested. In this section, please
revise to state that the shares you are registering represent 100% of the company's
currently issued and outstanding common stock and that all such shares may be freely
sold upon effectiveness of the registration statement. State that none of your
outstanding shares may be freely sold in reliance on an exemption from registration
such as Rule 144 at this time.
Exhibit Index
Exhibit 23.1, page II-5
7.Please have the consent revised to refer to the correct registration form being filed.
            Please contact Aamira Chaudhry at 202-551-3389 or Doug Jones at 202-551-3309 if
you have questions regarding comments on the financial statements and related
matters. Please contact Cara Wirth at 202-551-7127 or Lilyanna Peyser at 202-551-3222 with
any other questions.
Sincerely,
Division of Corporation Finance
Office of Trade & Services
cc:Joseph Lucosky